Glaxosmithkline Trading Services Limited
SpainAll drugs from this manufacturer
-
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps facilitate the entry and exit of air from the lungs by preventing the airway muscles from contracting.
Dosage form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 74,2 µg vilanterol trifenilacetate 40 µg -
It is used to treat the symptoms of allergic rhinitis, such as nasal congestion, increased nasal discharge, itchy nose, sneezing, watery eyes, and itchy or red eyes.
Dosage form: suspension, nasal spray
Active substance Dosage fluticasone furoate 27,5 µg -
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps relax the lung muscles, reduce swelling, and make breathing easier.
Dosage form: powder for inhalation, single-dose
Active substance Dosage fluticasone furoate 92 µg umeclidinium 55 µg vilanterol 22 µg -
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps prevent the contraction of the lung muscles, facilitating the intake and release of air.
Dosage form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 74,2 µg -
It is used in adults to treat a type of cancer called endometrial cancer (cancer of the uterine lining), whether it is newly diagnosed, has spread, cannot be operated on, or has progressed after previous treatment.
Dosage form: solution for infusion, concentrate
Active substance Dosage dostarlimab 500 mg -
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps facilitate the intake and release of air from the lungs by preventing the airway muscles from contracting.
Dosage form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 65 µg vilanterol trifenilacetate 35,2 µg -
It is used to treat severe eosinophilic asthma in adults, adolescents, and children aged 6 years and older. It is also used to treat chronic rhinosinusitis with nasal polyps, chronic obstructive pulmonary disease (COPD), eosinophilic granulomatosis with polyangiitis (EGPA), and hypereosinophilic syndrome (HES) in adults.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage mepolizumab Igual a 100 mg mg -
It is used to treat severe asthma (specifically eosinophilic asthma), Eosinophilic Granulomatosis with Polyangiitis (EGPA), chronic rhinosinusitis with nasal polyps (CRSwNP), chronic obstructive pulmonary disease (COPD), and hypereosinophilic syndrome (HES).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage mepolizumab 100 mg -
It is used to treat severe asthma in adults, adolescents, and children aged 6 years and older, specifically in cases of eosinophilic asthma (when there are too many eosinophils in the blood and lungs).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage mepolizumab 40 mg -
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with increased spleen size or other related symptoms, and who also have moderate to severe anemia.
Dosage form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 121,94 mg -
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with an enlarged spleen or other related symptoms, and who also suffer from moderate to severe anemia.
Dosage form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 182,91 mg -
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with an enlarged spleen or other related symptoms, and who also suffer from moderate to severe anemia.
Dosage form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 243,88 mg -
It is used for the regular treatment of chronic obstructive pulmonary disease (COPD) in adults, and for the treatment of asthma in adults and adolescents aged 12 years or older.
Dosage form: powder for inhalation, single-dose
Active substance Dosage vilanterol trifenilacetate 25 µg fluticasone furoate 200 µg -
It is used for the regular treatment of chronic obstructive pulmonary disease (COPD) in adults, and for the treatment of asthma in adults and adolescents aged 12 years or older.
Dosage form: powder for inhalation, single-dose
Active substance Dosage vilanterol trifenilacetate 25 µg fluticasone furoate 100 µg -
It is used for the regular treatment of asthma in adults and adolescents aged 12 years or older, and for the treatment of chronic obstructive pulmonary disease (COPD) in adults. It helps control breathing difficulties by reducing inflammation and opening the airways.
Dosage form: powder for inhalation, single-dose
Active substance Dosage fluticasone furoate 184 µg vilanterol 22 µg -
It is used for the regular treatment of asthma in adults and adolescents aged 12 years or older, and for the treatment of chronic obstructive pulmonary disease (COPD) in adults. It helps control breathing difficulties by reducing inflammation and relaxing the airway muscles.
Dosage form: powder for inhalation, single-dose
Active substance Dosage fluticasone furoate 92 µg vilanterol 22 µg -
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps prevent the contraction of lung muscles, making breathing easier.
Dosage form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 65 µg -
It is used to treat chronic obstructive pulmonary disease (COPD) in adults, helping to reduce swelling and irritation in the airways to make breathing easier.
Dosage form: powder for inhalation, single-dose
Active substance Dosage fluticasone furoate 92 µg umeclidinium bromide 55 µg vilanterol trifenilacetate 22 µg -
It is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps widen the pulmonary arteries to facilitate the pumping of blood from the heart to the lungs.
Dosage form: tablets, film-coated
Active substance Dosage ambrisentan 10 mg -
It is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps widen the pulmonary arteries to facilitate the pumping of blood from the heart to the lungs.
Dosage form: tablets, film-coated
Active substance Dosage ambrisentan 2,5 mg -
It is used to treat pulmonary arterial hypertension (PAH) in adults, adolescents, and children aged 8 years and older. It helps widen the pulmonary arteries to facilitate the pumping of blood from the heart to the lungs.
Dosage form: tablets, film-coated
Active substance Dosage ambrisentan 5 mg -
It is used to treat chronic hepatitis B infection in adults.
Dosage form: tablets, film-coated
Active substance Dosage lamivudine 100 mg -
It is used to treat chronic hepatitis B infection in adults. It helps reduce the amount of virus in the body, which can improve liver function.
Dosage form: solution, oral
Active substance Dosage lamivudine 5 mg -
It is used in adult women to treat ovarian, fallopian tube, or peritoneal cancer, specifically in cases that have responded to platinum-based chemotherapy or that have recurred after such treatment.
Dosage form: tablets, film-coated
Active substance Dosage niraparib tosylate monohydrate 159,3 mg